Search

everythinglearnresearchcommunity

for

Search:↓

The document explains how certain drugs block hormones to treat cancers like breast and prostate cancer.

The document concludes that sex hormones and related compounds have various effects on health, with both potential benefits and risks.

Subcutaneous injections of platelet-rich plasma may help with hair loss.

Dutasteride showed some prevention of prostate issues but also had limitations, especially with high-grade tumors.

A new method was developed to analyze certain hormones and drugs in human blood efficiently.

5ARIs effectively treat and manage BPH by reducing prostate size and symptoms.

5α-reductase inhibitors lower overall prostate cancer risk but not high-grade cancer risk; longer-term screening and new treatments show promise.

Larger prostate size in older men may be linked to poorer semen quality and fertility issues.

The conclusion is that doctors should be careful when prescribing 5α-reductase inhibitors due to possible serious side effects, and they should discuss these risks with patients.

Dutasteride effectively treats benign prostatic obstruction, improves urinary flow, reduces prostate size, and may prevent prostate cancer, but can cause sexual side effects.

Combination drug therapies are more effective for high-risk BPS patients but have more side effects and costs.

Hair growth issues can be linked to genetics, diseases, or medications, and new treatments are being developed.

Some prostate cancers have gene changes that may affect treatment with certain drugs.

The editorial concludes that the field of hair loss treatment has become more scientific and that effective treatments are important for self-esteem and job prospects.

The document concludes that individualized treatments for hair issues are effective, certain hair changes can indicate neurocutaneous diseases, specific lotions improve skin health, laser hair removal works but needs more study on long-term effects, men's cosmetics are diverse, peeling is effective but can have side effects, and facial pigmentation is often due to overactive skin cells.

Male pattern baldness is mainly caused by a hormone called dihydrotestosterone (DHT), and drugs that can block this hormone might help prevent hair loss.

Antiandrogens are used to manage polycystic ovary syndrome by reducing androgen levels or controlling their effects, often combined with lifestyle changes and other treatments.

Finasteride and dutasteride may cause macular abnormalities.

Finasteride can cause lasting erectile dysfunction, low libido, and depression in some patients.

Dutasteride helps increase hair density in patients with female-pattern hair loss by activating a new growth mechanism.

Dutasteride injections can help hair growth in androgenic alopecia but need more research for long-term use.

Long use of finasteride and dutasteride can cause long-term erection problems.

Sebocytes play a key role in controlling androgen levels in human skin.

New treatments for PCOS focus on insulin resistance and reducing testosterone levels, along with traditional hormone therapies.

Oral ivermectin effectively cured scabies with minimal side effects, and finasteride promoted hair growth in men with hair loss.

A drug improved schizophrenia-like symptoms in stressed rats by changing brain steroid levels.

Finasteride can treat prostatic haematuria, but its use is controversial.

Finasteride reduces hair growth in women with hirsutism and works better with electrolysis.

Male tissue has more cell death than female tissue after ischemia, and some neurosteroids only protect female cells.

Finasteride doesn't affect ovulation in normal women.